Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.

Special Class

PT&RT

SPC03--Airway Clearance

Wednesday, September 25, 2024
8:00 AM - 5:00 PM ET
Location: 252 A
Ticketed Session
This Special Class, ‘Airway Clearance" all day course will cover the use of the following evidence based Airway Clearance Techniques: Active Cycle of Breathing Technique (ACBT), Autogenic Drainage (AD), Positive Expiratory Pressure (PEP) therapy, Oscillating PEP therapy and HFCWO. This session will focus on the use of ACT from birth through adolescence to adulthood. This will include positioning, family dynamics, adherence issues, managing the asymptomatic patient together with those with advancing lung disease. This will include those who qualify for CFTR Modulators. There will be practical sessions with breakout groups to discuss issues and management of the different ages, life-stages, pathophysiology and treatment strategies.

Learning Objectives:

  • Discuss the uses of the different types of evidence based Modern Airway Clearance Techniques available including Active Cycle of Breathing Technique; Autogenic Drainage; Positive Expiratory Pressure (PEP); Oscillating PEP and external oscillating devices; physical exercise as ACT – for those on highly effective CFTR modulators and those who do not qualify
  • Describe situations when Airway Clearance Therapy is contra-indicated or to be used with caution and/or modified eg. hemoptysis, pneumothorax, gastroesophageal reflux, segmental collapse/consolidation or mucus retention/plugging
  • Explain how CFTR modulators may influence different types of ACT and their dosage when people with CF are stable and with acute exacerbations with mild, moderate and severe lung disease.